Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-14

Clinical Trial Update: Stem Cell in Acute Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating stem cell therapy for acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem cell therapy (stem cell)

Snippet

Sponsor: PT. Prodia Stem Cell Indonesia | Conditions: Acute Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED